Sonova Holding (OTCMKTS:SONVY) Given Consensus Rating of “Hold” by Brokerages

Sonova Holding (OTCMKTS:SONVY) has received a consensus recommendation of “Hold” from the seven analysts that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating on the company.

SONVY has been the topic of a number of research analyst reports. Morgan Stanley upgraded Sonova from an “underweight” rating to an “equal weight” rating in a report on Tuesday, June 23rd. Citigroup restated a “sell” rating on shares of Sonova in a research report on Friday, July 24th. Finally, UBS Group raised Sonova from a “hold” rating to a “buy” rating in a research note on Wednesday, July 22nd.

Sonova Stock Performance

OTCMKTS SONVY opened at $60.83 on Monday. The stock has a 50 day simple moving average of $52.82 and a two-hundred day simple moving average of $50.11. Sonova has a fifty-two week low of $42.26 and a fifty-two week high of $61.09. The company has a current ratio of 1.75, a quick ratio of 1.43 and a debt-to-equity ratio of 0.51.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.